An article published by Merlin researchers from UNIPD has recently been published in the “Leukemia” journal. The piece is entitled “Mouse mesenchymal stem cells inhibit high endothelial cell activation and lymphocyte homing to lymph nodes by releasing TIMP-1” (Author(s): Zanotti L, Angioni R, Calì B, Soldani C, Ploia C, Moalli F, Gargesha M, D’Amico G, Elliman S, Tedeschi G, Maffioli E, Negri A, Zacchigna S, Sarukhan A, Stein JV, Viola A) and appears in the May issue. The article deals with the impact of MSC on immunity and inflammation and identifies TIMP-1 as a novel biomarker for MSC-based therapy. You can access the article here.
- RT @EU_Health: Monitoring the #safety of #blood, #tissues and #cells in the EU: > 25 million donations of blood & > 2 million units of ti… Time ago 2 Days via Twitter Web Client
- Data continues to be held by the study team and is only shared with data requestors following a successful data acc… t.co/FDNuFc04QC Time ago 3 Days via Hootsuite
- @RAIScuola Time ago 4 Days via Hootsuite
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.